NR4A3 and neoplasm: As mentioned before, the translocation of the active enhancer regions from the SCPP gene cluster to the upstream region of NR4A3 leads to upregulation of the latter through enhancer hijacking, leading to oncogenic effects and tumor proliferation [26,27,28].